In any normal week, I see quite a few updates from the FDA regarding companies they've sent warning letters to, actions they've taken against illegitimate companies and more. This week, however, I found it curious that they retracted a posted warning letter to Procter and Gamble regarding their NyQuil product with added vitamin C.

Part One in a three part series highlighting the negative effects of water in raw materials on our industry

As most of you know, Natural Products Expo East is at our doorstep, starting next Wednesday, September 23^rd through the 26^th...

This week there’s been quite a bit of buzz surrounding Rebaudioside A, the latest and greatest hot topic.

There have been several times while in this industry when I really wished I didn't know what I know. In at least a dual role (editor and CEO), I find myself privy to information that should not be publicly disclosed, but is important enough for the future and integrity of the industry, that morally, it needs to be at least shared - in principle. Even if only to let others know what to watch for, the signs and signals of self-destructive behavior, in some cases, especially if we really do care about...

Read More »

Industry not-for-profit Nourish America needs a bit of help as it works on the "Centrum Ultra’s My Ultra Goals Sweepstakes". Help pass the word.

FDA receives “32 reports of liver injury including 27 requiring hospitalization” in users of GlaxoSmithKline’s Alli OTC weight loss drug.  FDA receives 23 reports of liver injury including one death in users of the dietary supplement Hydroxycut.  Guess which one is still on the market.

Lets talk about microencapsulated fat-soluble vitamins.  There are many forms, and several new encapsulants have appeared over the past few years. 

The Wall Street Journal reports that industry affected by proposed health-care reform spent $133 million lobbying on the issue before Congress last quarter. How do you think the supplement industry stacks up?